Search Results for: compassionate use

Dozen Finalists for Stem Cell Person of the Year 2013

Stem-cell-person-of-the-year-award

The voting is over and we have our top 12 finalists for the 2013 Stem Cell Person of the Year Award. You can see the final votes results below. It’s definitely an intriguing list that reflects the range of important areas in the field today. I can say without any hesitation that all 12 of …

Dozen Finalists for Stem Cell Person of the Year 2013 Read More »

My response to ‘Our Bodies, Our Cells’ Harvard post on deregulation

Mary-Ann-Chirba

Over at the Harvard Law “Bill of Health” blog, Mary Ann Chirba and Alice A. Nobel posted a piece entitled “Our Bodies, Our Cells” a few days ago that has generated a lot of discussion about FDA regulation of stem cell interventions. Their piece really has two parts. In the first part they go through …

My response to ‘Our Bodies, Our Cells’ Harvard post on deregulation Read More »

8 simple reasons not to get an unlicensed stem cell treatment part 2: lack of follow-up

I’m doing a series of posts on straightforward reasons why patients should not get unlicensed stem cell treatments. Part 1 of the series was on the risk of losing medical insurance coverage. Today is part 2, which is focused on a serious failing of many for-profit, point-of-care stem cell clinics selling unlicensed treatments: lack of …

8 simple reasons not to get an unlicensed stem cell treatment part 2: lack of follow-up Read More »

Money and stem cell ‘miracles’: Pluristem questioned on ethics

Pluristem Therapeutics Inc. is a publicly traded (NASDAQ) biotech Israeli company that is developing stem cell treatments based on the use of expanded placental stem cells called PLX cells. The Pluristem PLX drug is not approved for treating patients at this time in any country, however Pluristem has treated a handful of patients via something …

Money and stem cell ‘miracles’: Pluristem questioned on ethics Read More »

Some thoughts on taking risks in science & medicine

taking-risks-e1513621401309

Are you a risk-taker or do you do everything possible to avoid risks? Taking risks in science is necessary, but is there a wise way to take the risks you do? Science and medicine need a certain amount of risk and risk-takers to make transformative leaps forward. The risks in biomedical science can be conceptual …

Some thoughts on taking risks in science & medicine Read More »

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur

Right-To-Try-Debate-Roxland-Sandefur

Should patients have the Right To Try experimental therapies that could be unsafe and ineffective? What if those patients have a terminal illness and no reasonable prospects of being helpful to conventional medicine? Doesn’t it make perfect sense to let them try a risky approach if they want to do so? On the other hand, …

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur Read More »

Reviews of my new book GMO Sapiens on #CRISPR & human modification

GMO-Sapiens-Book-Cover

It’s exciting that the reviews are starting to come in on my new book, GMO Sapiens, on human genetic modification including CRISPR. Here is one from The Scientist and the book was recommended by Scientific American. Reviews from individual authors and scientists are below. “GMO Sapiens could not be more timely. New technologies like CRISPR-Cas9 gene …

Reviews of my new book GMO Sapiens on #CRISPR & human modification Read More »